Scientists from the Complutense Universit... - Cure Parkinson's

Cure Parkinson's

25,550 members26,870 posts

Scientists from the Complutense University of Madrid have found, after a four-year study, that Ayahuasca is capable of forming neurons

Farooqji profile image
3 Replies

thecostaricanews.com/ayahua...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
3 Replies
Bolt_Upright profile image
Bolt_Upright

"When applying the treatment in humans, the drug would have to be administered with inhibitors of this enzyme so that the DMT reaches the brain and, in addition, with a hallucinogenic receptor antagonist to avoid these side effects, the scientists insist."

Oh no thank you, I will gladly take the side effect with the medicine.

Bolt_Upright profile image
Bolt_Upright

I thought I had seen Ayahuasca recently: Woman, 29, took her own life after 'suffering psychosis from hallucinogenic yoga drugs' EXCLUSIVE: Jennifer Spencer's trip to Peru with her 'healer' boyfriend saw her seek enlightenment by drinking psychoactive brew ayahuasca for Kundalini yoga - but her aunt said she fell into a 'sort of psychosis' mirror.co.uk/news/uk-news/w...

Not enough to scare me off.

Bolt_Upright profile image
Bolt_Upright

Looks pretty good.

Here is another link: Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease 2020 pubmed.ncbi.nlm.nih.gov/321...

Conclusion: The lower doses of the active samples stimulated neuronal cell proliferation and/or displayed the most efficacious neuroprotection profile, namely by preventing neuronal damage and improving cell viability against 6-OHDA-induced toxicity. Intriguingly, the hydroalcoholic fractions exhibited enhanced neuroprotective effects when compared to other samples and isolated alkaloids. This finding corroborates the significance of a holistic approach. The results demonstrate that Ayahuasca and its base plants have potential applicability for PD treatment and to prevent its progression differently from current drugs to treat PD.